Candriam SCA’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.59M Sell
512,681
-21,391
-4% -$317K 0.04% 293
2025
Q1
$9.57M Buy
+534,072
New +$9.57M 0.06% 243